{"disease":{"id":"diabetic-retinopathy-visually-threatening","name":"diabetic retinopathy visually threatening"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03665090","title":"Shanghai Cohort Study of Diabetic Eye Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":8000,"lead_sponsor_name":"Shanghai Eye Disease Prevention and Treatment Center","has_results":false},{"nct_id":"NCT04380064","title":"Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Rush Eye Associates","has_results":false},{"nct_id":"NCT06549023","title":"Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Vastra Gotaland Region","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}